BioCentury
ARTICLE | Financial News

Mirati Therapeutics financial update

July 29, 2013 7:00 AM UTC

Mirati voluntarily delisted from the Toronto Stock Exchange. The company will continue trading on NASDAQ. The company reincorporated in the U.S. from Canada and changed its name to Mirati from Methyl...